TARSUS PHARMACEUTICALS, INC. (TARS) /
The profitability of TARSUS PHARMACEUTICALS, INC. over the past 8 years
Chart TARSUS PHARMACEUTICALS, INC.: operating income, net income, fiscal 2018–2025 Open the chart →TARSUS PHARMACEUTICALS, INC. reported a net loss of $66.42M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $70.97M. It reported a loss in all 7 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$70.97M | -$66.42M |
| 2024ended Dec 31, 2024 | -$120.57M | -$115.55M |
| 2023ended Dec 31, 2023 | -$143.16M | -$135.89M |
| 2022ended Dec 31, 2022 | -$62.71M | -$62.09M |
| 2021ended Dec 31, 2021 | -$12.16M | -$13.83M |
| 2020ended Dec 31, 2020 | -$27M | -$26.81M |
| 2019ended Dec 31, 2019 | -$4.3M | -$4.67M |
| 2018 | — | — |
Fiscal years as TARSUS PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TARSUS PHARMACEUTICALS, INC.
- The revenue of TARSUS PHARMACEUTICALS, INC.
- The cash flow of TARSUS PHARMACEUTICALS, INC.
- The debt of TARSUS PHARMACEUTICALS, INC.
- All of TARSUS PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTCTNETSCOUT SYSTEMS INC
- PRVAPrivia Health Group, Inc.
- BWINThe Baldwin Insurance Group, Inc.
- WSCWillscot Holdings Corporation
- EXTRExtreme Networks, Inc.
Not investment advice. This page shows what TARSUS PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.